1Knvner MS, Cutler N, Feighner J, et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science, 1998, 281 (5383) :1640 - 1645.
2Stephen MS. Peptides and psychiatry - Part 3 : Substance P and Serendipi~ : novel psychotropics are a possibility. J Clin Psychiatry,1999, 60:(3)140-141.
3Saria A. The tachykinin NK1 receptor in the brain : pharmacology and putative functions. Eur J phannacol, 1999,375 ( 1 - 3 ) :51 - 60.
4Ribeiro - da - Silva A, Hokfelt T. Neuroanatomical localisation of substance P in the CNS and sensory neurons. Neuropeptides, 2000,34(5) :256 -271.
5Richant Hargreaves. Imaging substance P receptors( NK1 ) in the llving human brain using positron emission tomography. J clin Psychiatry 2002,63 (suppl 11) :18 -24.
6Fiebich BL, Hollig A, Lieb K. Inhibition of substance P - induced cytokine synthesis by St. John's wort extracts. Pharmacopsychiatry,2001,34( suppl 1) :S26 - S28.
7Rupniak N M J, Carlson El, Webb JK, et al. Comparison of the phenotype of NK1R - / - mice with pharmacological blockade of the substance P( NK1 ) receptor in assays for antidepressant and anxiolytic drugs. Behavioloural Pharmacology 2001 ;12(6 -7) :497 -508.
8Rupniak NM,Carlson EC, Harrison T, et al. Pharmacological blockade or genetic deletion of substance P ( NK1 ) receptors attenhates neonatal vocalisation in guinea - pigs and mice. Neurophannacology 2000,39(8) :1413 - 1421.
9Bupniak NM, Knuner MS. Discovery of the antidepressant and antiemetic efficacy of substance P receptor ( NK1 ) antagonists. Trends Phannacol Sci 1999,20(12) :485 -490.
10Hart VD, MGC, Cz6h B, et al. Substance P receptor antagonist and clomipramine prevent stress - induced alterations in cerebral metabolites, cytogenesis in the dendate gyrus and hippoeampal volume.Molecular Psychiatry 2002,7 (9) :933 - 941.
